Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs

被引:51
|
作者
Smith, Steven J. [1 ]
Zhao, Xue Zhi [2 ]
Passos, Dario Oliveira [3 ]
Lyumkis, Dmitry [3 ,4 ]
Burke, Terrence R., Jr. [2 ]
Hughes, Stephen H. [1 ]
机构
[1] NCI, HIV Dynam & Replicat Program, Ctr Canc Res, Frederick, MD 21702 USA
[2] NCI, Chem Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA
[3] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
来源
VIRUSES-BASEL | 2021年 / 13卷 / 02期
关键词
HIV; integration; INSTIs; drug resistance; antiviral therapy;
D O I
10.3390/v13020205
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Integrase strand transfer inhibitors (INSTIs) are currently recommended for the first line treatment of human immunodeficiency virus type one (HIV-1) infection. The first-generation INSTIs are effective but can select for resistant viruses. Recent advances have led to several potent second-generation INSTIs that are effective against both wild-type (WT) HIV-1 integrase and many of the first-generation INSTI-resistant mutants. The emergence of resistance to these new second-generation INSTIs has been minimal, which has resulted in alternative treatment strategies for HIV-1 patients. Moreover, because of their high antiviral potencies and, in some cases, their bioavailability profiles, INSTIs will probably have prominent roles in pre-exposure prophylaxis (PrEP). Herein, we review the current state of the clinically relevant INSTIs and discuss the future outlook for this class of antiretrovirals.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Pro-drugs of Strand Transfer Inhibitors of HIV-1 Integrase: Inhibition Data, Structure-Activity Analysis and Anti-HIV Activity
    Nair, Vasu
    Seo, Byung
    Nishonov, Malik
    Okello, Maurice
    Mishra, Sanjay
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A40 - A40
  • [2] Integrase Strand Transfer Inhibitors in HIV Therapy
    Mesplède T.
    Wainberg M.A.
    Infectious Diseases and Therapy, 2013, 2 (2) : 83 - 93
  • [3] Design and development of integrase inhibitors as anti-HIV agents
    Gupta, SP
    Nagappa, A
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (18) : 1779 - 1794
  • [4] Advances in the development of HIV integrase strand transfer inhibitors
    Wang, Yue
    Gu, Shuang-Xi
    He, Qiuqin
    Fan, Renhua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225
  • [5] Structural Biology of HIV Integrase Strand Transfer Inhibitors
    Jozwik, Ilona K.
    Passos, Dario O.
    Lyumkis, Dmitry
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (09) : 611 - 626
  • [6] HIV-1 Integrase Strand Transfer Inhibitors
    Johns, Brian A.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 263 - +
  • [7] The strand transfer oligonucleotide inhibitors of HIV-integrase
    Snasel, Jan
    Rosenberg, Ivan
    Paces, Ondrej
    Pichova, Iva
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2009, 24 (01) : 241 - 246
  • [8] Are anti-HIV drugs an effective treatment?
    Karpas, A
    Ash, S
    Bainbridge, D
    NATURE MEDICINE, 1997, 3 (10) : 1052 - 1052
  • [9] Are anti-HIV drugs an effective treatment?
    Richard J. Wurtman
    Nature Medicine, 1997, 3 : 1052 - 1052
  • [10] Are anti-HIV drugs an effective treatment?
    Abraham Karpas
    Stephen Ash
    Douglas Bainbridge
    Nature Medicine, 1997, 3 : 1052 - 1052